# A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

> **NCT01181167** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 610 (actual)

## Conditions studied

- Prevention
- Venous Thromboembolism

## Interventions

- **DRUG:** edoxaban
- **DRUG:** enoxaparin sodium

## Key facts

- **NCT ID:** NCT01181167
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-01
- **Final completion:** 2010-03
- **Target enrollment:** 610 (ACTUAL)
- **Last updated:** 2019-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181167, "A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01181167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*